| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/23/2008 | CN101164542A Use of mometasone furoate for preparing drug |
| 04/23/2008 | CN101164539A New use of staurosporine derivatives |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100382819C Nephritis treating medicinal capsule |
| 04/23/2008 | CN100382816C Chinese medicinal composition for treating chronic bronchitis and its preparation method |
| 04/23/2008 | CN100382805C Azithromycin enteric casing microsphere and its preparing process |
| 04/23/2008 | CN100382786C Bastard feverfew throat clearing drip pill and its preparation method |
| 04/23/2008 | CN100382785C Cough suppressing phlegm transforming drip pill and its preparation method |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361668 Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 04/22/2008 | US7361660 Chemical compounds |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | CA2443970C Apparatus and method for nasal rinse |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2279963C Dinucleotides and their use |
| 04/17/2008 | WO2008046087A2 Spiro compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044109A1 Reconstituted surfactants having improved properties |
| 04/17/2008 | WO2008019372A3 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 04/17/2008 | WO2008003748A3 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
| 04/17/2008 | WO2007143745A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/17/2008 | WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof |
| 04/17/2008 | US20080090873 Sulfonamide derivatives |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090841 pyrazinoylguanidine derivatives; more potent, more specific, and/or absorbed less rapidly from mucosal surfaces, and/or are less reversible, give a prolonged pharmacodynamic half-life; treating anthrax, chronic bronchitis, cystic fibrosis,chronic obstructive pulmonary disease, emphysema, pneumonia |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090779 2-Benzyloxy-5-(2-bromoacetyl)-N-[3,5-bis(trifluoromethyl)phenyl-benzamide; diseases caused by production of immunoglobulin E: inflammatory cytokine, histamine, leukotriene and degranulation from activated mast cell; pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis, hysteromyoma |
| 04/17/2008 | US20080090224 Nucleic acid detection |
| 04/17/2008 | US20080089956 Nitric oxide in treatment of inflammation |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089849 Powders for inhalation |
| 04/17/2008 | CA2666344A1 Reconstituted surfactants having improved properties |
| 04/17/2008 | CA2665764A1 Pharmaceutical anti-infective composition for inhalation |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911749A1 New long-working Beta-2 agonists and their use as medicine |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911448A2 Lipoxins and Aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/16/2008 | EP1910358A2 Heterocyclic janus kinase 3 inhibitors |
| 04/16/2008 | EP1910354A2 Novel method for producing tiotropium salts |
| 04/16/2008 | EP1910314A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 04/16/2008 | EP1909812A2 Small compounds that correct protein misfolding and uses thereof |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1633376B1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| 04/16/2008 | EP1567526B1 Carbamic acid esters with anticholinergic action |
| 04/16/2008 | EP1169353B1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101163706A Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 04/16/2008 | CN101163681A Phthalazinone derivative and pharmaceutical comprising the same |
| 04/16/2008 | CN101163677A Crystalline forms of a biphenyl compound |
| 04/16/2008 | CN101163673A New muscarinic receptor antagonists |
| 04/16/2008 | CN101163484A The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis |
| 04/16/2008 | CN101163480A Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161278A A relieving cough dropping pills and its preparing method |
| 04/16/2008 | CN101161264A A Chinese medicine preparation for easing-off head and neck neoplasm radiotheraphy secondary reaction |
| 04/16/2008 | CN101161258A A Chinese medicine capsule for treating sinusitis |
| 04/16/2008 | CN101161256A Fossil oral liquid |
| 04/16/2008 | CN101161252A A pellet type isatis root effervescent and its preparing method |
| 04/16/2008 | CN101161240A Levodropropizine medicinal composition for oral cavity use |
| 04/16/2008 | CN101161124A Health beverage |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381423C Novel piperidine derivatives as modulators of chemokine receptor CCR5 |
| 04/16/2008 | CN100381162C Application of medicine and food dual purpose Chinese medicinal product in preventing and treating wind-cold common cold |
| 04/16/2008 | CN100381123C Granules of clarityne and their production method |
| 04/16/2008 | CN100381120C Fibrauretine powder for injection and its production process |
| 04/16/2008 | CN100381118C Soft achyranthes capsule and its preparation method |
| 04/16/2008 | CN100381114C Medicine prepn for treating laryngopharyngitis and its preparation method |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358260 Quinuclidine derivatives and medicinal compositions containing the same |
| 04/15/2008 | US7358258 Prodrugs of an ERK protein kinase inhibitor |
| 04/15/2008 | US7358245 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 04/15/2008 | US7358222 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 04/15/2008 | US7358093 Aztreonam L-lysine and methods for the preparation and analysis thereof |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2263201C Cross-protective equine herpesvirus preparations and method of making and using the same |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/10/2008 | WO2008043031A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/10/2008 | WO2008043019A1 8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression |